RGENRepligen Corporation

$7B

Q4 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$52M+24.8% YoY

Gross Profit

$29M55.7% margin

Operating Income

$8M15.1% margin

Net Income

$6M10.9% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+4.9%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$98,000

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$139M

Total Liabilities

$159M

Stockholders' Equity

$616M

Cash & Equivalents

$194M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$42M	+24.8%
Gross Profit	$29M	$22M	+28.7%
Operating Income	$8M	$3M	+140.8%
Net Income	$6M	$12M	-53.7%

Revenue Segments

Product

$52M100%

Royalty

$93,0000%

RGEN Q4 2018 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena